EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Adding a Rapid PCR-Based Blood Culture Identification Panel to the Antimicrobial Stewardship Program of Patients with Febrile Neutropenia in a Peruvian Referral Hospital

Giancarlo Pérez-Lazo iD, Juana Del Valle-Mendoza, Roxana Sandoval-Ahumada, Fernando Soto-Febres, Raúl Castillo-Córdova iD, Melissa Zárate-Tantaleán, Liliana Morales-Castillo, Celia Joanna Páucar-Miranda, Milagros Altamirano-Molina iD, Iván Pacheco-Modesto, Claudia Ruiz de Somocurcio-Cruzado, Denis Arana-Jurado und 8 weitere

Antibiotics · 24.03.2023 · 12 (4) · 648

DOI: 10.3390/antibiotics12040648 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 24.03.2023. Verfasst von Giancarlo Pérez-Lazo und 19 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Medicina, Universidad César Vallejo, Piura 20001, Peru. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Independent research grant from Pfizer (Investigator Sponsored Research (ISR), Investigator Sponsored Research (ISR)-Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The addition of Biofire® FilmArray® Blood Culture Identification panel 2 (BCID2) to the antimicrobial stewardship program (ASP) could improve outcomes in bloodstream infections (BSI) of patients with febrile neutropenia (FN). A pre- and post-quasi-experimental single-center study was conducted at a reference hospital in Peru. Three groups were considered: patients with BSI before ASP intervention (control group), patients with BSI after ASP intervention (group 1), and patients with BSI after ASP intervention plus BCID2 PCR Panel implementation (group 2). Overall, 93 patients were identified (32 control, 30 group 1, 31 group 2). The median time to effective therapy was significantly shorter in group 2 compared to group 1 and control group, respectively (3.75 vs. 10 h, p = 0.004; 3.75 vs. 19 h, p < 0.001). No significant differences in terms of relapse of bacteremia, in-hospital mortality (all cause), and 30-day-all-cause hospital readmission between the three study periods were found. The appropriateness of empirical antimicrobial use, adding or change, and the following de-escalation or discontinuation was significant when the two intervention periods were compared with the control group (p < 0.001). In addition to the lack of local studies documenting the microbiological profile of FN episodes, adding syndromic panels-based testing could allow for the consolidation of ASP strategies.

Schlagwörter

Stichwörter der Autor:innen

Peruantimicrobial stewardshipfebrile neutropeniaoutcome

Autor:innen und Institutionen

  • Escuela de Medicina, Universidad César Vallejo, Piura 20001, Peru.
  • Division of Infectious Diseases, Guillermo Almenara Irigoyen National Hospital-EsSalud, Lima 15033, Peru.
  • Centro de Investigación e Innovación de la Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas, Lima 15023, Peru.
  • Clinical Pathology Department, Guillermo Almenara Irigoyen National Hospital-EsSalud, Lima 15033, Peru.
  • Clinical Hematology Service, Guillermo Almenara Irigoyen National Hospital-EsSalud, Lima 15033, Peru.

ORCID-Profile: Giancarlo Pérez-Lazo, Raúl Castillo-Córdova, Milagros Altamirano-Molina, Miguel Angel Aguilar-Luis, Johanna Martins-Luna

Förderung

  • Independent research grant from Pfizer (Investigator Sponsored Research (ISR)
  • Investigator Sponsored Research (ISR)-Pfizer

Zitieren

APA

Pérez-Lazo, G., Del Valle-Mendoza, J., Sandoval-Ahumada, R., Soto-Febres, F., Castillo-Córdova, R., Zárate-Tantaleán, M., Morales-Castillo, L., Páucar-Miranda, C. J., Altamirano-Molina, M., Pacheco-Modesto, I., Ruiz de Somocurcio-Cruzado, C., Arana-Jurado, D., Del Villar-Alarcón, C., Vargas-Castro, O., Díaz-Bardales, C., Guerrero-Arismendiz, B., Eyzaguirre-Zapata, R., Aguilar-Luis, M. A., Martins-Luna, J., & Silva-Caso, W. (2023). Impact of Adding a Rapid PCR-Based Blood Culture Identification Panel to the Antimicrobial Stewardship Program of Patients with Febrile Neutropenia in a Peruvian Referral Hospital. Antibiotics, 12(4), 648. https://doi.org/10.3390/antibiotics12040648

Vancouver

Pérez-Lazo G, Del Valle-Mendoza J, Sandoval-Ahumada R, Soto-Febres F, Castillo-Córdova R, Zárate-Tantaleán M, et al. Impact of Adding a Rapid PCR-Based Blood Culture Identification Panel to the Antimicrobial Stewardship Program of Patients with Febrile Neutropenia in a Peruvian Referral Hospital. Antibiotics. 2023;12(4):648. doi:10.3390/antibiotics12040648

BibTeX
@article{PrezLazo2023,
  author = {Pérez-Lazo, Giancarlo and Del Valle-Mendoza, Juana and Sandoval-Ahumada, Roxana and Soto-Febres, Fernando and Castillo-Córdova, Raúl and Zárate-Tantaleán, Melissa and Morales-Castillo, Liliana and Páucar-Miranda, Celia Joanna and Altamirano-Molina, Milagros and Pacheco-Modesto, Iván and Ruiz de Somocurcio-Cruzado, Claudia and Arana-Jurado, Denis and Del Villar-Alarcón, Carmen and Vargas-Castro, Olga and Díaz-Bardales, Carol and Guerrero-Arismendiz, Bruno and Eyzaguirre-Zapata, Renee and Aguilar-Luis, Miguel Angel and Martins-Luna, Johanna and Silva-Caso, Wilmer},
  title = {Impact of Adding a Rapid PCR-Based Blood Culture Identification Panel to the Antimicrobial Stewardship Program of Patients with Febrile Neutropenia in a Peruvian Referral Hospital},
  journal = {Antibiotics},
  year = {2023},
  volume = {12},
  number = {4},
  pages = {648},
  doi = {10.3390/antibiotics12040648}
}
Kostenlos starten →